Can procalcitonin monitoring reduce the length of antibiotic treatment in bloodstream infections?

International Journal of Antimicrobial Agents

Volumn 46, Issue , 2015, Pages S10-S12

  Pantelidou, Iliana Maria ^a   Giamarellos Bourboulis, Evangelos J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Bloodstream infections; Procalcitonin; Treatment duration

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CALCA PROTEIN, HUMAN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; PROTEIN PRECURSOR;

ARTICLE; BACTERIAL ENDOCARDITIS; BLOODSTREAM INFECTION; DRUG EFFICACY; ESCHERICHIA COLI; HUMAN; HYPOTENSION; INFECTION RISK; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MULTICENTER STUDY (TOPIC); NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; SURVIVAL; TREATMENT DURATION; TREATMENT OUTCOME; BLOOD; DRUG MONITORING; DRUG THERAPY; PROCEDURES; SEPSIS; TIME;

ANTI-BACTERIAL AGENTS; BIOMARKERS; CALCITONIN; CALCITONIN GENE-RELATED PEPTIDE; DRUG MONITORING; DRUG THERAPY; HUMANS; PROTEIN PRECURSORS; SEPSIS; TIME;

EID: 84949525073     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.10.005     Document Type: Article

References (19)

1. S.E. Cosgrove The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs Clin Infect Dis 42 Suppl 2 2006 S82 S89
2. G. Elhanan, M. Sarhat, and R. Raz Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection J Infect 35 1997 283 288
3. E.D. Carrol, A.P. Thomson, and C.A. Hart Procalcitonin as a marker of sepsis Int J Antimicrob Agents 20 2002 1 9
4. P. Linscheid, D. Seboek, D.J. Schaer, H. Zulewski, U. Keller, and B. Muller Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes Crit Care Med 32 2004 1715 1721
5. M. Assicot, D. Gendrel, H. Carsin, J. Raymond, J. Guilbaud, and C. Bohuon High serum procalcitonin concentrations in patients with sepsis and infection Lancet 341 1993 515 518
6. P. Schuetz, V. Chiappa, M. Briel, and J.L. Greenwald Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms Arch Intern Med 171 2011 1322 1331
7. A. Kumar, D. Roberts, K.E. Wood, B. Light, J.E. Parrillo, S. Sharma, and et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 34 2006 1589 1596
8. E. Bouza, D. Sousa, P. Muñoz, M. Rodríguez-Créixems, C. Fron, and J.G. Lechuz Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results Clin Infect Dis 39 2004 1161 1169
9. M. Koupetori, T. Retsas, N. Antonakos, G. Vlachogiannis, I. Perdios, C. Nathanail, and et al. Bloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcome BMC Infect Dis 14 2014 272
10. A.P. Georgopoulou, A. Savva, E.J. Giamarellos-Bourboulis, M. Georgitsi, M. Raftogiannis, N. Antonakos, and et al. Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis J Crit Care 26 2011 331.e1-7
11. P. Schuetz, P. Maurer, V. Punjabi, A. Desai, D.N. Amin, and E. Gluck Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients Crit Care 17 2013 R115
12. P. Schuetz, M. Christ-Crain, R. Thomann, C. Falconnier, M. Wolbers, I. Widmer, and et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial JAMA 302 2009 1059 1066
13. S. Schroeder, M. Hochreiter, T. Koehler, A.M. Schweiger, B. Bein, F.S. Keck, and et al. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study Langenbecks Arch Surg 394 2009 221 226
14. A. Hohn, S. Schroeder, A. Gehrt, K. Bernhardt, B. Bein, K. Wegscheider, and et al. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock BMC Infect Dis 13 2013 158
15. J.U. Jensen, L. Hein, B. Lundgren, M.H. Bestle, T.T. Mohr, M.H. Andersen, and et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial Crit Care Med 39 2011 2048 2058
16. J.B. Knudsen, K. Fuursted, E. Petersen, P. Wierup, H. Mølgaard, S.H. Poulsen, and et al. Procalcitonin in 759 patients clinically suspected of infective endocarditis Am J Med 123 2010 1121 1127
17. C. Mueller, P. Huber, G. Laifer, B. Mueller, and A.P. Perruchoud Procalcitonin and the early diagnosis of infective endocarditis Circulation 109 2004 1707 1710
18. M. Jereb, T. Kotar, T. Jurca, and T. Lejko Zupanc Usefulness of procalcitonin for diagnosis of infective endocarditis Intern Emerg Med 4 2009 221 226
19. F. Cuculi, S. Toggweiler, M. Auer, Ch.A. der Maur, M. Zuber, and P. Erne Serum procalcitonin has the potential to identify Staphylococcus aureus endocarditis Eur J Clin Microbiol Infect Dis 27 2008 1145 1149